Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

It's in the Genes

In an age of "pre-existing conditions," can a new bill help patients get the treatment they need?
Sep 2, 2007

In an age of "pre-existing conditions," can a new bill help patients get the treatment they need?

Court Dissolves Schering-Plough Consent Decree

Aug 9, 2007

Schering-Plough announced today that a consent decree filed against the company in May, 2002, had been dissolved by the US District Court for the District of New Jersey in Newark.

A Moral Decision, A Vital Consequence

By vetoing stem cell research funding, the President is vetoing potentially life-saving treatments.
Aug 2, 2007

By vetoing stem cell research funding, the President is vetoing potentially life-saving treatments.

From Boon to Bubble?

Infrastructure must be in place before jumping into outsourcing.
Aug 1, 2007

Infrastructure must be in place before jumping into outsourcing.

New FDA Guidance on Polymorphic Compounds in Generic Drugs

Jul 12, 2007

A new guidance issued by the US Food and Drug Administration earlier this month advises companies on how to treat polymorphic drug compounds?those that exhibit multiple structural forms?in filing abbreviated new drug applications.

Survey Says Two Million US Adults Import Drugs without Prescriptions

Jul 5, 2007

More than five million US adults import prescription drugs from other countries, according to a survey conducted by the Pharmaceutical Research and Manufacturers of America.

Standing the Test of Time

Thirty years ago, the world was a very different place; so was the pharma industry.
Jul 2, 2007

Thirty years ago, the world was a very different place; so was the pharma industry.

Balancing Act

Perhaps Congress can help FDA meet its multiple oversight demands.
Jun 2, 2007

Perhaps Congress can help FDA meet its multiple oversight demands.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here